- Home
- MSGM vs PHIO Comparison
MSGM vs PHIO Comparison
Compare MSGM & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGM
- PHIO
- Stock Information
- Founded
- MSGM 2018
- PHIO 2011
- Country
- MSGM United States
- PHIO United States
- Employees
- MSGM N/A
- PHIO N/A
- Industry
- MSGM Computer Software: Prepackaged Software
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- MSGM Technology
- PHIO Health Care
- Exchange
- MSGM Nasdaq
- PHIO Nasdaq
- Market Cap
- MSGM 14.0M
- PHIO 12.1M
- IPO Year
- MSGM 2021
- PHIO N/A
- Fundamental
- Price
- MSGM $2.41
- PHIO $2.14
- Analyst Decision
- MSGM
- PHIO Strong Buy
- Analyst Count
- MSGM 0
- PHIO 3
- Target Price
- MSGM N/A
- PHIO $10.67
- AVG Volume (30 Days)
- MSGM 15.8K
- PHIO 70.7K
- Earning Date
- MSGM 11-06-2025
- PHIO 11-13-2025
- Dividend Yield
- MSGM N/A
- PHIO N/A
- EPS Growth
- MSGM N/A
- PHIO N/A
- EPS
- MSGM 0.00
- PHIO N/A
- Revenue
- MSGM $8,127,065.00
- PHIO N/A
- Revenue This Year
- MSGM $69.07
- PHIO N/A
- Revenue Next Year
- MSGM $30.56
- PHIO N/A
- P/E Ratio
- MSGM $5.62
- PHIO N/A
- Revenue Growth
- MSGM N/A
- PHIO N/A
- 52 Week Low
- MSGM $0.73
- PHIO $0.97
- 52 Week High
- MSGM $3.92
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- MSGM 41.48
- PHIO 45.75
- Support Level
- MSGM $2.35
- PHIO $2.08
- Resistance Level
- MSGM $2.60
- PHIO $2.17
- Average True Range (ATR)
- MSGM 0.13
- PHIO 0.09
- MACD
- MSGM 0.01
- PHIO -0.01
- Stochastic Oscillator
- MSGM 45.45
- PHIO 23.36
About MSGM Motorsport Games Inc.
Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.